Pro-inflammatory effects of Burkholderia cepacia on cystic fibrosis respiratory epithelium

FEMS Immunology and Medical Microbiology

Volumn 38, Issue 3, 2003, Pages 273-282

  Fink, Joshua ^a   Steer, James H ^b   Joyce, David A ^b   McWilliam, Andrew S ^a,c   Stewart, Geoffrey A ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c CURTIN UNIVERSITY   (Australia)

Author keywords

Burkholderia cepacia; Cystic fibrosis transmembrane conductance regulator; Interleukin 6; Interleukin 8; Nuclear factor B; Prostaglandin E 2

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PROSTAGLANDIN E2; PROSTANOID; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; BURKHOLDERIA CEPACIA; CELL FREE SYSTEM; CELL STIMULATION; CYSTIC FIBROSIS; CYTOKINE RELEASE; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LUNG ALVEOLUS CELL TYPE 2; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SUPERNATANT;

EID: 0142074683     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00169-X     Document Type: Article

References (25)

1. Dimango E., Ratner A.J., Bryan R., Tabibi S., Prince A. Activation of NF-kappa-b by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J. Clin. Invest. 101:1998;2598-2605.
2. Davis, P.B. (1993) In: Cystic Fibrosis, Lung Biology in Health and Disease, Vol. 64 (Davis, P.B., Ed.), pp. 193-218. Marcel Dekker, New York.
3. Isles A., Maclusky I., Corey M., Gold R., Prober C., Fleming P., Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:1984;206-210.
4. Massengale A.R.D., Quinn F., Yankaskas J., Weissman D., McClellan W.T., Cuff C., Aronoff S.C. Reduced interleukin-8 production by cystic fibrosis airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 20:1999;1073-1080.
5. Palfreyman R.W., Watson M.L., Eden C., Smith A.W. Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (pseudomonas) cepacia products. Infect. Immun. 65:1997;617-622.
6. Bedard M., McClure C.D., Schiller N.L., Francoeur C., Cantin A., Denis M. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells - implications for cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 9:1993;455-462.
7. Black H.R., Yankaskas J.R., Johnson L.G., Noah T.L. Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-alpha and respiratory syncytial virus stimulation. Am. J. Respir. Cell Mol. Biol. 19:1998;210-215.
8. Schwiebert L.M., Estell K., Propst S.M. Chemokine expression in CF epithelia: implications for the role of CFTR in RANTES expression. Am. J. Physiol. 276:1999;C700-10.
9. Venkatakrishnan A., Stecenko A.A., King G., Blackwell T.R., Brigham K.L., Christman J.W., Blackwell T.S. Exaggerated activation of nuclear factor-kappa B and altered I kappa B-beta processing in cystic fibrosis bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 23:2000;396-403.
10. Meng Q.H., et al. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J. Pathol. 184:1998;323-331.
11. Kazachkov M., Lager J., LiPuma J., Barker P.M. Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids. Pediatr. Pulmonol. 32:2001;338-340.
12. Yamamoto Y., Gaynor R.B. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107:2001;135-142.
13. Bauernfeind A., Schneider I., Jungwirth R., Roller C. Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR. J. Clin. Microbiol. 37:1999;1335-1339.
14. Lieber M., Smith B., Szakal A., Nelson-Rees W., Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int. J. Cancer. 17:1976;62-70.
15. Kunzelmann K., Schwiebert E.M., Zeitlin P.L., Kuo W.L., Stanton B.A., Gruenert D.C. An immortalized cystic fibrosis tracheal epithelial cell line homozygous for the delta F508 CFTR mutation. Am. J. Respir. Cell Mol. Biol. 8:1993;522-529.
16. Zeitlin P.L., Lu L., Rhim J., Cutting G., Stetten G., Kieffer K.A., Craig R., Guggino W.B. A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am. J. Respir. Cell Mol. Biol. 4:1991;313-319.
17. Asokananthan N., Graham P.T., Fink J., Knight D.A., Bakker A.J., McWilliam A.S., Thompson P.J., Stewart G.A. Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E-2 release from human respiratory epithelial cells. J. Immunol. 168:2002;3577-3585.
18. Steer J.H., Kroeger K.M., Abraham L.J., Joyce D.A. Glucocorticoids suppress tumor necrosis factor-alpha expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-kappa B and c-Jun-activating transcription factor-2 binding sites in the promoter. J. Biol. Chem. 275:2000;18432-18440.
19. Kammouni W., Figarella C., Marchand S., Merten M. Altered cytokine production by cystic fibrosis tracheal gland serous cells. Infect. Immun. 65:1997;5176-5183.
20. Pugin J., Schurer-Maly C.C., Leturcq D., Moriarty A., Ulevitch R.J., Tobias P.S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA. 90:1993;2744-2748.
21. Tavakoli S., Cowan M.J., Benfield T., Logun C., Shelhamer J.H. Prostaglandin E(2)-induced interleukin-6 release by a human airway epithelial cell line. Am. J. Physiol. 280:2001;L127-33.
22. Wojtczak H.A., Kerby G.S., Wagener J.S., Copenhaver S.C., Gotlin R.W., Riches D.W., Accurso F.J. Beclomethasone diproprionate reduced airway inflammation without adrenal suppression in young children with cystic fibrosis: a pilot study. Pediatr. Pulmonol. 32:2001;293-302.
23. Vanden Berghe W., De Bosscher K., Boone E., Plaisance S., Haegeman G. The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J. Biol. Chem. 274:1999;32091-32098.
24. Yasumoto K., Okamoto S., Mukaida N., Murakami S., Mai M., Matsushima K. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene. J. Biol. Chem. 267:1992;22506-22511.
25. Schmedtje J.F., Ji Y.S., Liu W.L., DuBois R.N., Runge M.S. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem. 272:1997;601-608.